T11	Drug 583 591	miR-125b
T12	Disease 595 597	AD
T13	Biomarker 599 635	MiR-125b was found highly expression
T14	Disease 639 641	AD
T15	Chemical 963 974	sphingosine
T16	Biomarker 1029 1060	aberrant expression of miR-125b
T2	Disease 43 45	AD
#7	AnnotatorNotes T2	DOID:10652
T3	Biomarker 50 83	serum miR-125b was down-regulated
T4	Disease 87 89	AD
T5	Biomarker 169 199	decreased circulating miR-125b
T6	Disease 257 259	AD
T8	Biomarker 306 336	reduced expression of miR-125b
T9	Drug 404 417	17β-estradiol
T19	RNA-Noncoding 30 38	miR-125b
T20	RNA-Noncoding 56 64	miR-125b
T21	RNA-Noncoding 191 199	miR-125b
T22	RNA-Noncoding 328 336	miR-125b
T23	RNA-Noncoding 599 607	MiR-125b
T24	RNA-Noncoding 676 684	miR-125b
T25	Gene-Protein 922 927	FOXQ1
T26	Gene-Protein 905 920	forkhead box Q1
T27	Gene-Protein 985 990	SphK1
T28	Gene-Protein 963 983	sphingosine kinase 1
T29	RNA-Noncoding 1052 1060	miR-125b
R1	Association Arg1:T13 Arg2:T14	
T31	Gene-Protein 827 831	CDK5
T33	Gene-Protein 836 842	p35/25
T34	Gene-Protein 952 957	Bcl-W
R2	Association Arg1:T3 Arg2:T4	
T1	RNA-Noncoding 497 505	miR-125b
T36	Gene-Protein 275 277	Aβ
T37	Gene-Protein 222 225	APP
T7	Gene-Protein 447 457	Aβ-peptide
T38	Disease 447 478	Aβ-peptide caused neurotoxicity
T39	Gene-Protein 692 695	tau
#1	AnnotatorNotes T38	not found
R3	Protects-from Arg1:T9 Arg2:T38	
T10	Disease 1102 1104	AD
#2	AnnotatorNotes T9	CHEMBL135
#3	AnnotatorNotes T11	C531888
#4	AnnotatorNotes T10	DOID:10652
T17	Gene-Protein 226 229	PS1
T18	Biomarker 1080 1098	neural dysfunction
#5	AnnotatorNotes T36	not found
#6	AnnotatorNotes T7	not found
#8	AnnotatorNotes T39	HGNC:6893
#9	AnnotatorNotes T31	HGNC:1774
#10	AnnotatorNotes T33	HGNC:1775
T35	Gene-Protein 844 855	p44/42-MAPK
#11	AnnotatorNotes T35	HGNC:6877
#12	AnnotatorNotes T26	HGNC:20951
#13	AnnotatorNotes T25	HGNC:20951
#14	AnnotatorNotes T34	HGNC:995
#15	AnnotatorNotes T28	HGNC:11240
#16	AnnotatorNotes T27	HGNC:11240
T30	Drug 659 684	Up-regulation of miR-125b
R4	Response Arg1:T30 Arg2:T14	
